title: [Management of erectile dysfunction in the cardiac patient].
authors.affiliation: Urologische Klinik und Poliklinik der LMU München. Christian.Gratzke@med.uni-muenchen.de
authors.forename: C
authors.initials: C
authors.lastname: Gratzke
authors.forename: A J
authors.initials: AJ
authors.lastname: Becker
authors.forename: J-W
authors.initials: JW
authors.lastname: Park
authors.forename: O
authors.initials: O
authors.lastname: Reich
authors.forename: E
authors.initials: E
authors.lastname: Waldkirch
authors.forename: B
authors.initials: B
authors.lastname: Schlenker
authors.forename: C G
authors.initials: CG
authors.lastname: Stief
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases; D002423:Cause of Death; D003327:Coronary Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D004734:Energy Metabolism / Q000502:physiology; D006801:Humans; D018783:Impotence, Vasculogenic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D010353:Patient Education as Topic; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010727:Phosphoric Diester Hydrolases / Q000187:drug effects; D010808:Physical Examination; D012307:Risk Factors
chemical_list: D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human